Role of calcium in the pathogenesis of Alzheimer’s disease and transgenic models

Subcellular Biochemistry

Volumn 45, Issue , 2007, Pages 507-521

  Green, K N ^a   Smith, I F ^a   LaFerla, Frank M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Amyloid beta; Calcium; Cognition; Long term potentiation; Transgenic

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM; ION CHANNEL;

ALZHEIMER DISEASE; ANIMAL; DRUG EFFECT; HOMEOSTASIS; HUMAN; METABOLISM; MOUSE; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNAPSE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CALCIUM; HOMEOSTASIS; HUMANS; ION CHANNELS; MICE; MICE, TRANSGENIC; NEURONAL PLASTICITY; SYNAPSES;

EID: 38849132181     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-6191-2_19     Document Type: Article

References (85)

1. Arispe, N., Rojas, E., and Pollard, H. B. (1993). Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A 90, 567-571.
2. Bennett, B. D., Denis, P., Haniu, M., Teplow, D. B., Kahn, S., Louis, J. C., Citron, M., and Vassar, R. (2000). A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta-secretase. J Biol Chem 275, 37712-37717.
3. Benzing, W. C., Wujek, J. R., Ward, E. K., Shaffer, D., Ashe, K. H., Younkin, S. G., and Brunden, K. R. (1999). Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 20, 581-589.
4. Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., and LaFerla, F. M. (2005). Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
5. Bliss, T. V., and Collingridge, G. L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
6. Bobich, J. A., Zheng, Q., and Campbell, A. (2004). Incubation of nerve endings with a physiological concentration of Abeta1-42 activates CaV2.2(N-Type)-voltage operated calcium channels and acutely increases glutamate and noradrenaline release. J Alzheimers Dis 6, 243-255.
7. 2+ channel currents requires a functional electron transport chain. J Biol Chem 280, 21706-21712.
8. Caccamo, A., Oddo, S., Billings, L. M., Green, K. N., Martinez-Coria, H., Fisher, A., and LaFerla, F. M. (2006). M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49, 671-682.
9. Chapman, P. F., White, G. L., Jones, M. W., Cooper-Blacketer, D., Marshall, V. J., Irizarry, M., Younkin, L., Good, M. A., Bliss, T. V., Hyman, B. T., et al. (1999). Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci 2, 271-276.
10. Chen, M., and Fernandez, H. L. (2004). Stimulation of beta-amyloid precursor protein alpha-processing by phorbol ester involves calcium and calpain activation. Biochem Biophys Res Commun 316, 332-340.
11. Chen, Q. S., Kagan, B. L., Hirakura, Y., and Xie, C. W. (2000). Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 60, 65-72.
12. Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., and Holtzman, D. M. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913-922.
13. 2+ exchange activity is increased in Alzheimer's disease brain tissues. Brain Res 543, 139-147.
14. Coon, A. L., Wallace, D. R., Mactutus, C. F., and Booze, R. M. (1999). L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue. Neurobiol Aging 20, 597-603.
15. Cruz, J. C., Tseng, H. C., Goldman, J. A., Shih, H., and Tsai, L. H. (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483.
16. DeKosky, S. T., Scheff, S. W., and Styren, S. D. (1996). Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5, 417-421.
17. Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I., and Glabe, C. G. (2005). Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294-17300.
18. Ekinci, F. J., Malik, K. U., and Shea, T. B. (1999). Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration. J Biol Chem 274, 30322-30327.
19. Fahrenholz, F., and Postina, R. (2006). Alpha-secretase activation-an approach to Alzheimer's disease therapy. Neurodegener Dis 3, 255-261.
20. Garlind, A., Cowburn, R. F., Forsell, C., Ravid, R., Winblad, B., and Fowler, C. J. (1995). Diminished [3H]inositol(1,4,5)P3 but not [3H]inositol(1,3,4,5)P4 binding in Alzheimer's disease brain. Brain Res 681, 160-166.
21. Gibson, G. E., Nielsen, P., Sherman, K. A., and Blass, J. P. (1987). Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients. Biol Psychiatry 22, 1079-1086.
22. Goto, Y., Niidome, T., Akaike, A., Kihara, T., and Sugimoto, H. (2006). Amyloid beta-peptide preconditioning reduces glutamate-induced neurotoxicity by promoting endocytosis of NMDA receptor. Biochem Biophys Res Commun 351, 259-265.
23. Green, K. N., and Peers, C. (2001). Amyloid beta peptides mediate hypoxic augmentation of Ca(2+) channels. J Neurochem 77, 953-956.
24. Green, K. N., and Peers, C. (2002). Divergent pathways account for two distinct effects of amyloid beta peptides on exocytosis and Ca(2+) currents: involvement of ROS and NF-kappaB. J Neurochem 81, 1043-1051.
25. Greenamyre, J. T., Penney, J. B., D'Amato, C. J., and Young, A. B. (1987). Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding. J Neurochem 48, 543-551.
26. Grynspan, F., Griffin, W. R., Cataldo, A., Katayama, S., and Nixon, R. A. (1997). Active site-directed antibodies identify calpain II as an early-appearing and pervasive component of neurofibrillary pathology in Alzheimer's disease. Brain Res 763, 145-158.
27. Hedin, H. L., Eriksson, S., and Fowler, C. J. (2001). Human platelet calcium mobilisation in response to beta-amyloid (25-35): buffer dependency and unchanged response in Alzheimer's disease. Neurochem Int 38, 1450-151.
28. Hirashima, N., Etcheberrigaray, R., Bergamaschi, S., Racchi, M., Battaini, F., Binetti, G., Govoni, S., and Alkon, D. L. (1996). Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Neurobiol Aging 17, 549-555.
29. Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998). Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97-100.
30. Huang, H. M., Toral-Barza, L., Thaler, H., Tofel-Grehl, B., and Gibson, G. E. (1991). Inositol phosphates and intracellular calcium after bradykinin stimulation in fibroblasts from young, normal aged and Alzheimer donors. Neurobiol Aging 12, 469-473.
31. 2+ homeostasis in lymphoblasts from patients with late-onset Alzheimer disease. Alzheimer Dis Assoc Disord 11, 220-227.
32. Kawahara, M., and Kuroda, Y. (1997). [Molecular mechanism of neuronal death in Alzheimer's disease: Ca(2+)-channel formation of beta amyloid protein molecules]. Tanpakushitsu Kakusan Koso 42, 2002-2010.
33. Kishimoto, A., Mikawa, K., Hashimoto, K., Yasuda, I., Tanaka, S., Tominaga, M., Kuroda, T., and Nishizuka, Y. (1989). Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain). J Biol Chem 264, 4088-4092.
34. LaFerla, F. M. (2002). Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3, 862-872.
35. Lee, M. S., and Tsai, L. H. (2001). Cdk5 at the junction. Nat Neurosci 4, 340-342.
36. Leissring, M. A., Akbari, Y., Fanger, C. M., Cahalan, M. D., Mattson, M. P., and LaFerla, F. M. (2000). Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J Cell Biol 149, 793-798.
37. Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., and Cole, G. M. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21, 8370-8377.
38. Liu, F., Grundke-Iqbal, I., Iqbal, K., Oda, Y., Tomizawa, K., and Gong, C. X. (2005). Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 280, 37755-37762.
39. Liu, Q., Kawai, H., and Berg, D. K. (2001). beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci U S A 98, 4734-4739.
40. Liu, Y., Peterson, D. A., and Schubert, D. (1998). Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis. Proc Natl Acad Sci U S A 95, 13266-13271.
41. Liu, Y., and Schubert, D. (1997). Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis. J Neurochem 69, 2285-2293.
42. Morris, R. G., Anderson, E., Lynch, G. S., and Baudry, M. (1986). Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774-776.
43. Nabeshima, T., and Nitta, A. (1994). Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. Tohoku J Exp Med 174, 241-249.
44. Nomura, I., Kato, N., Kita, T., and Takechi, H. (2005). Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons. Neurosci Lett 391, 1-6.
45. Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., and LaFerla, F. M. (2004). Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321-332.
46. Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B. P., and LaFerla, F. M. (2003a). Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063-1070.
47. Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., and LaFerla, F. M. (2003b). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
48. Oddo, S., Caccamo, A., Tran, L., Lambert, M. P., Glabe, C. G., Klein, W. L., and LaFerla, F. M. (2006). Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 281, 1599-1604.
49. 2+]i-level of fibroblasts from Alzheimer patients and control individuals. Neurochem Res 26, 817-820.
50. Peskind, E. R., Potkin, S. G., Pomara, N., Ott, B. R., Graham, S. M., Olin, J. T., and McDonald, S. (2006). Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial. Am J Geriatr Psychiatry 14, 704-715.
51. Peterson, C., Gibson, G. E., and Blass, J. P. (1985). Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. N Engl J Med 312, 1063-1065.
52. Peterson, C., and Goldman, J. E. (1986). Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci U S A 83, 2758-2762.
53. Peterson, C., Ratan, R. R., Shelanski, M. L., and Goldman, J. E. (1986). Cytosolic free calcium and cell spreading decrease in fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci U S A 83, 7999-8001.
54. Peterson, C., Ratan, R. R., Shelanski, M. L., and Goldman, J. E. (1988). Altered response of fibroblasts from aged and Alzheimer donors to drugs that elevate cytosolic free calcium. Neurobiol Aging 9, 261-266.
55. Petryniak, M. A., Wurtman, R. J., and Slack, B. E. (1996). Elevated intracellular calcium concentration increases secretory processing of the amyloid precursor protein by a tyrosine phosphorylationdependent mechanism. Biochem J 320 (Pt 3), 957-963.
56. Pettit, D. L., Shao, Z., and Yakel, J. L. (2001). beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J Neurosci 21, RC120.
57. Pierrot, N., Ghisdal, P., Caumont, A. S., and Octave, J. N. (2004). Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J Neurochem 88, 1140-1150.
58. Pontremoli, S., Melloni, E., Michetti, M., Sparatore, B., Salamino, F., Sacco, O., and Horecker, B. L. (1987). Phosphorylation by protein kinase C of a 20-kDa cytoskeletal polypeptide enhances its susceptibility to digestion by calpain. Proc Natl Acad Sci U S A 84, 398-401.
59. 2+ currents in rat cerebellar granule neurones. Neuroreport 9, 539-545.
60. Querfurth, H. W., Jiang, J., Geiger, J. D., and Selkoe, D. J. (1997). Caffeine stimulates amyloid betapeptide release from beta-amyloid precursor protein-transfected HEK293 cells. J Neurochem 69, 1580-1591.
61. Querfurth, H. W., and Selkoe, D. J. (1994). Calcium ionophore increases amyloid beta peptide production by cultured cells. Biochemistry 33, 4550-4561.
62. Ramsden, M., Plant, L. D., Webster, N. J., Vaughan, P. F., Henderson, Z., and Pearson, H. A. (2001). Differential effects of unaggregated and aggregated amyloid beta protein (1-40) on K(+) channel currents in primary cultures of rat cerebellar granule and cortical neurones. J Neurochem 79, 699-712.
63. Ripova, D., Platilova, V., Strunecka, A., Jirak, R., and Hoschl, C. (2004). Alterations in calcium homeostasis as biological marker for mild Alzheimer's disease? Physiol Res 53, 449-452.
64. Ripovi, D., Platilova, V., Strunecka, A., Jirak, R., and Hoschl, C. (2000). Cytosolic calcium alterations in platelets of patients with early stages of Alzheimer's disease. Neurobiol Aging 21, 729-734.
65. Saito, K., Elce, J. S., Hamos, J. E., and Nixon, R. A. (1993). Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90, 2628-2632.
66. 2+ channels. Faseb J 19, 150-152.
67. Shi, J., Townsend, M., and Constantine-Paton, M. (2000). Activity-dependent induction of tonic calcineurin activity mediates a rapid developmental downregulation of NMDA receptor currents. Neuron 28, 103-114.
68. Shi, X. P., Chen, E., Yin, K. C., Na, S., Garsky, V. M., Lai, M. T., Li, Y. M., Platchek, M., Register, R. B., Sardana, M. K., et al. (2001). The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain. J Biol Chem 276, 10366-10373.
69. Sinha, S., and Lieberburg, I. (1999). Cellular mechanisms of beta-amyloid production and secretion. Proc Natl Acad Sci U S A 96, 11049-11053.
70. Smith, I. F., Green, K. N., and LaFerla, F. M. (2005). Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals. Cell Calcium 38, 427-437.
71. Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., and Greengard, P. (2005). Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8, 1051-1058.
72. 2+ influx in PC12h cells in culture. Neurosci Lett 173, 147-150.
73. Taylor, S. C., Batten, T. F., and Peers, C. (1999). Hypoxic enhancement of quantal catecholamine secretion. Evidence for the involvement of amyloid beta-peptides. J Biol Chem 274, 31217-31222.
74. Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., and Katzman, R. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30, 572-580.
75. 2+ regulation and gene expression in normal brain aging. Trends Neurosci 27, 614-620.
76. 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126, 981-993.
77. 2+ channels: a possible involvement of free radicals. J Neurochem 68, 265-271.
78. Ulas, J., and Cotman, C. W. (1997). Decreased expression of N-methyl-D-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain. Neuroscience 79, 973-982.
79. Veeranna, Kaji, T., Boland, B., Odrljin, T., Mohan, P., Basavarajappa, B. S., Peterhoff, C., Cataldo, A., Rudnicki, A., Amin, N., et al. (2004). Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease. Am J Pathol 165, 795-805.
80. Walsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., El Agnaf, O., Hartley, D. M., and Selkoe, D. J. (2005). Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J Neurosci 25, 2455-2462.
81. Wu, J., Kuo, Y. P., George, A. A., Xu, L., Hu, J., and Lukas, R. J. (2004). beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. J Biol Chem 279, 37842-37851.
82. Yasar, S., Corrada, M., Brookmeyer, R., and Kawas, C. (2005). Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. Neurobiol Aging 26, 157-163.
83. Ye, C., Walsh, D. M., Selkoe, D. J., and Hartley, D. M. (2004). Amyloid beta-protein induced electrophysiological changes are dependent on aggregation state: N-methyl-D-aspartate (NMDA) versus non-NMDA receptor/channel activation. Neurosci Lett 366, 320-325.
84. Yoo, A. S., Cheng, I., Chung, S., Grenfell, T. Z., Lee, H., Pack-Chung, E., Handler, M., Shen, J., Xia, W., Tesco, G., et al. (2000). Presenilin-mediated modulation of capacitative calcium entry. Neuron 27, 561-572.
85. Young, L. T., Kish, S. J., Li, P. P., and Warsh, J. J. (1988). Decreased brain [3H]inositol 1,4,5- trisphosphate binding in Alzheimer's disease. Neurosci Lett 94, 198-202.